My issue isn’t with the risk per se, it is the lack of data collection and informed consent of the participants.I don't often disagree with you LL, but I think half assed isn't the right way to put it. The UK took a huge chance but it was based on what was already known about vaccines and how we generally react to them. We've got most things wrong during the pandemic no doubt, but I think the dosage strategy was an informed, calculated risk.
It was essentially a change in dosage trial of a drug (itself with a very short history) but without a) any control group comparison b) any real time data collection and I’ll stress again c) informed consent of the participants.
Do I think doing such a trial was supported by the facts on the ground and general vaccine knowledge - yes. But mRNA vaccines are very new, we don’t know a great deal about them so data collection to my mind has to be a key part of any rollout. And ethically I have a real issue with people not being given full information of the potential risk they are taking on.
